Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gustave Roussy, Cancer Campus, Grand Paris
With
Société Française des Cancers et Leucémies de l'Enfant et de l'Adolescent (SFCE)
Age
2–21
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. All cases of NHL corresponding to one of the following histologies:
* Burkitt and Burkitt-like (LB)
* Large cell B-cell lymphoma (LBGC)
* Primary mediastinal B cell lymphoma (LBPM)
* Lymphoblastic lymphoma (LL)
* Anaplastic large cell lymphoma (ALCL)
2. Age \> 2 years and \< 21 years
3. Treated in a SFCE protocol
4. Treated in a center with the possibility of organizing a PET / CT at the time of remission assessment
5. Affiliation to a social security system
6. Possible follow-up for at least 2 years
7. written informed consent signed by the parents or parental authority or the patient himself if he is over 18 years
You may not be if
1. relapsing patients
2. Patients with absolute cons-indications to the achievement of a PET scan: pregnancy, incontinence, poorly controlled diabetes or blood glucose\> 10 mmol/l, alterations of superior functions or claustrophobia, making the test impossible.
3. pre-existing or evolving infectious inflammatory disease making PET / CT difficult to interpret
Clareo Health | Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents
